JCM
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JCM Accepts, published online ahead of print on 12 December 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.00514-07v1
46/2/713    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inácio, J.
Right arrow Articles by Spencer-Martins, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inácio, J.
Right arrow Articles by Spencer-Martins, I.

 Previous Article  |  Next Article 

J. Clin. Microbiol. doi:10.1128/JCM.00514-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Efficient identification of clinically relevant yeasts combining a panfungal loop-mediated isothermal DNA amplification (LAMP) with hybridization to species-specific oligonucleotide probes

João Inácio, Orfeu Flores, and Isabel Spencer-Martins*

Centro de Recursos Microbiológicos (CREM), Department of Life Sciences, Faculty of Sciences and Technology, New University of Lisbon, 2829-516 Caparica, Portugal; STAB Vida Lda., Apartado 89, 2781-601 Oeiras, Portugal

* To whom correspondence should be addressed. Email: ism{at}fct.unl.pt.


   Abstract

The occurrence of invasive mycoses has progressively increased in recent years. Yeasts of the genus Candida remain the leading etiologic agents of those infections. Early identification of opportunistic yeasts may contribute significantly to improved disease management and the selection of appropriate antifungal therapy. We developed a rapid and reliable molecular identification system for clinically relevant yeasts which makes use of non-specific primers to amplify a region of the 26S rRNA gene, followed by reverse hybridization of the digoxigenin-labelled products to a panel of species-specific oligonucleotide probes arranged on a nylon membrane macroarray format. DNA amplification was achieved by the recently developed Loop-Mediated Isothermal DNA Amplification (LAMP) technology, a promising option for the development of improved laboratory diagnostic kits. The newly developed method was successful in discriminating among the major clinically relevant yeasts associated with bloodstream infections, using simple, rapid and cost-effective procedures and equipment.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.